Purified anti-APEX1 Antibody, APEX1, 1518CT337.123.86.269.232,BioLegend,605051

When using this clone for ICC, we recommend using PFA + methanol or methanol only fix-perm conditions. We do not recommend using PFA + Triton X-100 due to non-specific staining.When testing this clone for ICC, this antibody produced filamentous, extranuclear staining in some cells. This pattern was also observed with a control antibody generated using a different APEX1 immunogen, consistent with this staining being APEX1 dependent.

Host

Mouse

Reactivity

Human, Mouse

Application

WB - Quality testedIHC-P, ICC - Verified

Platform ID

BAB853825813

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-APEX1 Antibody, APEX1, 1518CT337.123.86.269.232
Cat. No.605051
HostMouse
RRIDAB_2910484 (BioLegend Cat. No. 605051)AB_2910484 (BioLegend Cat. No. 605052)
IsotypeMouse IgG1, κ
ReactivityHuman, Mouse
ApplicationWB - Quality testedIHC-P, ICC - Verified
ClonalityMonoclonal
Clone Number1518CT337.123.86.269.232
Concentration0.5 mg/mL
TargetAPEX1
ImmunogenFull-length recombinant human APEX1 protein
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

Apurinic-apyridimic endonuclease-1, or APEX1, is a multifunctional enzyme required for the repair of DNA damaged by both endogenous and exogenous agents. It also exerts oncogenic function as a redox signaling protein by reductively stimulating the DNA-binding activity of transcription factors that drive cancer progression, including c-Jun, AP-1, NF-κB, p53, and HIF1α. APEX1 expression level and subcellular localization are positively correlated with cancer progression, and elevated APEX1 expression may also confer resistance to DNA-damaging chemotherapeutic agents.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.